The disclosure relates to an electrosurgical device. More specifically, the disclosure relates to an electrosurgical probe and methods of use thereof.
U.S. Pat. No. 7,918,852 to Tullis et al. is for an electrosurgical system. It discloses an electrode assembly for lesioning that includes an electrode surrounded by layers of insulation and tubing but does not disclose cooling of the lesioning electrode.
Designer et al. (U.S. Pat. No. 7,828,799) discloses a probe having two distal region electrodes with the distal electrode tip having a cone shape that extends distally. Fluid in the lumen of the probe is spaced apart from the furthest point of the distal tip electrode.
Fay et al. (pending US Publication No. 2009/0156981) discloses a flexible catheter having a plastic tip and a plastic shaft tube with electrodes attached to it.
Some prior art bi-polar probes, such as those described in U.S. Pat. No. 7,828,799 to Desinger et al. and in pending US Publication No. 2009/0156981 to Fay et al., have configurations that allow cooling fluid to contact both the active electrode and the return electrode. As cooling fluid often has some conductivity, the flow of coolant between the electrodes will cause some energy to be transmitted within the probe rather than to surrounding tissue, resulting in a loss of effectiveness and possible safety concerns. The stray energy can also affect impedance measurements, causing further problems for devices that measure impedance.
In order that the invention may be readily understood, embodiments of the invention are illustrated by way of examples in the accompanying drawings, in which:
Radiofrequency-based devices are often used to create lesions in soft tissues such as the liver in order to treat tumors located therein. However, creating a lesion in bone tissue using an electrosurgical device for delivering electrical energy poses unique challenges due, for example, to the electrical properties of bone. The present inventors have discovered and reduced to practice various embodiments of a unique electrosurgical probe usable to create lesions in bone suitable for reducing pain and for reducing tumor burden.
In particular, inventors have discovered that an electrosurgical probe structured to confine delivery of energy at its active tip (i.e. without requiring energy to flow to a grounding pad on the surface of a body) is particularly useful in such situations. Furthermore, a bipolar probe used for lesioning in tissue can be cooled in order to increase the efficacy of energy delivery and lesion formation. More specifically, the probe may be internally cooled by including tubular electrodes configured such that the inner surface of each electrode is cooled while keeping the electrodes electrically isolated.
Some particular embodiments allow for cooling of more than one electrode while substantially confining the coolant to a lumen formed by one of the electrodes. Thus, for example, embodiments of the present invention include an electrosurgical probe comprising at least two electrically isolated conductors and a lumen for circulating a cooling fluid within only one of said at least two electrically isolated conductors, such that only one of the conductors is directly cooled by the cooling fluid. The cooling fluid circulating within the one conductor nonetheless functions to reduce the temperature of the at least two electrically isolated conductors.
The probe can include a means for temperature monitoring which is particularly advantageous when used, for example, in tissue that hinders the predictability of lesioning such as electrically insulative tissue.
As used herein, the term “bipolar probe” is understood to mean a probe that includes at least two electrically isolated electrodes whereby energy may be delivered between those electrodes in a manner which substantially confines the energy to an area substantially surrounding the active tip and obviates the need for a grounding pad or return electrode on the surface of a patient's body, thereby avoiding a flow of electrical energy through the patient's body from the active tip to such a grounding pad. Although the term “bipolar” is used herein, it should be understood to include other forms of energy delivery whereby energy flows substantially between electrodes located on the probe and not to a grounding pad on the surface of the patient's body.
In a first broad aspect of the invention, embodiments of a method of lesioning in bone are described, the method using a bipolar probe having an active tip comprising at least two electrodes for delivering energy, the method comprising the steps of: advancing the active tip into a bone tissue; delivering energy substantially between the at least two electrodes in a bipolar manner; and supplying cooling fluid to the active tip for internal cooling of the at least two electrodes. Some embodiments of the method further comprise the steps of monitoring the temperature of tissue to which the energy is being delivered; and controlling the delivery of energy in response to the temperature of the tissue to which the energy is being delivered.
In some embodiments of the first broad aspect, the bone is a vertebral body. In some such embodiments the energy is delivered to nervous tissue at a bone-tumor interface.
In embodiments of the first broad aspect wherein the bone is a vertebral body, the method comprises the further steps of: the probe being inserted into a vertebral body at a first target location to the right of a mid-saggital plane at an angle of about 15 to about 25 degrees to the mid-saggital plane and energy is delivered to form a first bipolar lesion at the first target location within the vertebral body; and the probe being inserted at a second target location to the left of the mid-saggital plane at an angle of about 15 to about 25 degrees from the mid-saggital plane and energy is delivered to form a second bipolar lesion at the second target location within the vertebral body.
In certain embodiments, the method comprises the active tip being advanced the into a trabecular bone. In some such embodiments an introducer assembly, comprising a cannula with a stylet disposed therein, is used to advance the probe into the vertebral body, and wherein the stylet is withdrawn from the cannula subsequent to the introducer assembly being advanced into the vertebral body.
In further embodiments using an introducer assembly, the introducer assembly is inserted into the vertebral body using a transpedicular approach. In some such embodiments, the introducer assembly is inserted through a pedicle at an angle of about 15 to about 25 degrees oblique to a mid-saggital plane.
In some such embodiments using an introducer assembly, the introducer assembly is inserted into the vertebral body using a lateral approach.
In particular embodiments of the method of the first broad aspect, the energy delivered to tissue is radiofrequency energy. In some embodiments, the temperature of the tissue is maintained at between about 40 degrees and about 100 degrees Celsius. In some embodiments, energy is delivered at power levels between about 1 Watt and about 20 Watts. In some embodiments, the energy is delivered for between about 2 minutes to about 30 minutes while, in alternate embodiments, the energy is delivered for less than about 2 minutes or for more than about 30 minutes. In some embodiments, the energy is delivered such that the temperature of the tissue increases at a ramp rate from about 10° C./min to about 80° C./min.
In some specific embodiments of the first broad aspect, the method further comprises reversing the polarity of the energy to the at least two electrodes.
In some such embodiments, the method further comprises: delivering a stimulation pulse of energy, comprising a continuous train of biphasic waves at a set frequency, to the probe; navigating the active tip through the bone tissue while delivering the stimulation pulse; reversing the polarity of the at least two electrodes while delivering the stimulation pulse to identify which electrode a stimulated nerve is in proximity to; and repeating the steps of delivering a stimulation pulse, navigating the active tip and reversing the polarity, until a location of the nerve is determined.
Furthermore, in some such embodiments, the method further comprises each probe being active for about 50 percent of the time.
Some embodiments further comprise: placing at least one external temperature sensor at a boundary of a desired lesion; monitoring the at least one external temperature sensor during energy delivery; and determining lesion completion when the external temperature reaches a predefined value.
In some embodiments of the first broad aspect, a temperature selected for the cooling fluid is from about 0 degrees C. to about 30 degrees C. Some such embodiments further comprise adjusting a flow rate of the cooling fluid.
In some embodiments of the first broad aspect, the energy is delivered to a nerve within a vertebral body. In some such embodiments the energy is delivered to a basivertebral nerve.
A second broad aspect of the invention is for embodiments of a method of treating pain generated by nervous tissue at an interface between bone of a vertebral body and a tumor located at least partially within the vertebral body. The method comprises: delivering energy to the nervous tissue using a single bipolar probe having an active tip comprising at least two electrodes, the energy being sufficient to limit generation of pain signals by the nervous tissue; and cooling the at least two electrodes as energy is being delivered to the nervous tissue to limit charring of the tissue at the surface of the at least two electrodes.
With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of certain embodiments of the present invention only. Before explaining at least one embodiment of the invention in detail it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.
Creating predictable lesions in insulative tissue such as bone can be aided by using a bipolar probe with internal cooling. Embodiments of such a probe include tubular electrodes configured such that the inner surface of each electrode is cooled, directly or indirectly, while keeping the electrodes electrically isolated. One possible configuration is an electrosurgical probe comprising two electrically isolated electrical conductors with an inner one of the conductors inside of the other and the inner electrical conductor defining a lumen for the circulation of a cooling fluid inside of it. The probe also has an electrical insulator layer between the electrical conductors for electrically isolating the electrical conductors. The electrical insulator has sufficient thermal conductivity to allow for cooling of the outside electrical conductors by cooling fluid circulating within the lumen of the inner electrical conductor. Thus, only one conductor is cooled directly, i.e. with contact of the cooling field, while the other conductor is indirectly cooled.
The inner elongate conductor 30 as shown in
In one example, the proximal electrode 52 is a return electrode and the cooling fluid cools the proximal electrode 52 prior to reaching and cooling the distal electrode 32, which is the active electrode. This may provide a more uniform lesion to be produced when RF energy is supplied to the probe 100. The structure of the probe 100, in one example, allows cooling fluid to indirectly cool the proximal electrode 52 and to directly cool the distal electrode 32. The cooling fluid flows through the inner lumen 34 of the inner conductor 30 and coaling is transmitted indirectly to the proximal electrode 52 through thermal conductivity through a wall of the inner conductor 30 and a wall of the inner insulator 40. Cooling fluid is supplied from the fluid inlet tube 21 which exits into the lumen 34 near the location of the proximal electrode 52. The relatively low temperature of the cooling fluid cools proximal electrode 52 indirectly, thus raising the temperature of the fluid. In other words, the cooling fluid allows heat to be removed from the proximal electrode 52. The fluid then flows within the lumen 34 to the distal electrode 32 at the slightly elevated temperature. Thus, cooling fluid at a lower temperature is used to indirectly cool the proximal electrode 52, whereas, cooling fluid that is at a slightly higher temperature passes through the distal electrode 32 to cool it directly. It is possible that by cooling proximal electrode 52 indirectly at a lower temperature and cooling the distal electrode 32 directly at a slightly higher temperature, cooling of electrodes 32, 52 will be substantially equivalent. This may allow cooling to be transmitted uniformly to both the proximal and distal electrodes 52, 32, thus allowing a relatively uniform heat distribution around the two electrodes. This may allow a more uniform lesion to be produced when the electrodes 32, 52 are placed in target tissue. Providing cooler fluid to cool the proximal electrode 52 may offset the difference in cooling at the proximal and distal electrodes 52, 32 due to direct and indirect cooling respectively.
In the case of the embodiment of
In one example, the cooling fluid may comprise water. In another example, the cooling fluid may comprise saline. In an alternate example an alcohol may be used. As a further example, an isopropyl alcohol may be used. In one embodiment the temperature of the cooling fluid may range from about its freezing point to about room temperature. In one embodiment, the fluid inlet and outlet tubes, 21, 22 may be constructed from a metal. In one example the fluid inlet and outlet tubes are made from stainless steel hypotubes and may be connected to the fluid supply at proximal ends thereof with non-conductive supply tubes 12, 14. These may comprise any non-conductive material such as a polymer. In one specific example, the supply tubes 12, 14 comprise of Polyvinylchloride (PVC) tubing that may be UV (ultraviolet) glued to the stainless steel inlet and outlet tubes 21, 22. In other embodiments, any other means can be used to join the supply tubes to the outlet tubes. In other embodiments the fluid inlet and outlet tubes 21, 22 may be constructed from a non-conductive material such as a polymer. In still other embodiments, the fluid inlet and outlet tubes 21, 22 may be formed of alternate materials. The fluid inlet and outlet tubes 21 and 22 may be positioned alongside each other within the inner lumen 34 of the inner conductor 30. In other embodiments any flow pathway may be provided to the probe 100 to allow fluid to enter the inner conductor 30 and exit thereform. The flow pathway may comprise a fluid inflow path that is separate from a fluid outflow path which provides directional flow. In some embodiments cooling fluid may be directed into the inner conductor 30 directly without use of the fluid inlet tube 21.
In one embodiment the active tip 70 may have a length (L1+L2+L3) that ranges from about 5 mm to about 40 mm. In one example, the length of the distal electrode 32 (L1), the exposed inner insulator 40 (L2), and the proximal electrode 52 (L3) may vary in about a 2:1:2 ratio. In other embodiments the ratio may be in about a 1:1:1 configuration. Alternate embodiments am possible as well. In other embodiments, the lengths L1, L2 and L3 may have a different ratio. In another example, the L1:L2:L3 ratio is about 7:6:7.
In another embodiment, the inner and outer conductors 30, 50 may only extend along a portion of the probe 100. In one example inner and outer conductors 30, 50 may be electrically conductive along their lengths thereof and may form the proximal and the distal electrodes, 32 and 52. In one specific example, as shown in
In this example, the distal and proximal electrodes 32 and 52 each define a closed inner lumen 34 and 54 respectively within which cooling fluid flows. The distal electrode 32 has a closed distal end and a closed proximal end formed by co-operative engagement of the distal electrode proximal portion with a distal face 43 of the inner insulator 40, defining the closed inner lumen 34. The proximal electrode 52 has a has a closed distal end formed by co-operative engagement of the proximal electrode distal end with the proximal face 45 of the inner insulator 40 as shown in
Additionally, a temperature sensor 80 may be positioned at a location along the probe 100 as shown in
In some embodiments a second temperature sensor is proximate to proximal electrode 52 and is in communication with a controller for the energy supply for providing additional information. Such an embodiment could be used with a generator capable of capable of monitoring two temperature sensors at one time. Alternatively, a generator capable of monitoring only one temperature at a time could be used if an external device swapped between the two (or more) temperature sensors.
Generally, embodiments of the present invention may comprise a plurality of temperature sensors, which may be located, for example, on or adjacent to the surface of the electrodes, between the electrodes or at or near the electrodes, proximally or distally. A generator used in system with two or more temperature sensors would include an algorithm for controlling the output of energy based on multiple temperature readings.
The inner conductor 30 has a closed distal end. As shown in
In some embodiments, the probe size may range from an outer diameter of about 13 Gauge, 2.413 mm (0.095″), to about 17 Gauge, 1.47 mm (0.058″). In one example, the probe 100 has a diameter of about 17 Gauge and has an outer conductor 50 with a length of about 215.9 mm (8.5″) and an inner conductor 30 with a length of about 228.6 mm (9.0″). The fluid outlet tube 22 has a length of about 241.3 mm (9.5″) and extends into the handle, whereas the fluid inlet tube 21 is about 38.1 mm (1.5″) in length and positioned at the proximal end of the inner conductor 30. The thermocouple hypotube 84 is positioned within the inner lumen 34 of inner conductor 30 and has a length of about 254 mm (10″).
In one example the insulators 40 and 60 may comprise a polyester. The insulators 40 and 60 may be disposed onto the conductors 30 and 50 respectively using a heat-shrink procedure. The conductors 30 and 50 may be electrically conductive along their length. In one example, the polyester is a Polyethylene terephthalate (PET). In other embodiments a polyamide, polyimide, Fluorinated ethylene propylene (FEP) or polytetrafluoroethylene (PTFE), may be used to form one or both of the insulators 40, 60. In one embodiment the insulators 40 or 60 may be provided in the form of a coating or a layer. In still other embodiments PEEK may be used. In one example the thickness of the inner insulator 40 may vary from about 0.0127 mm (0.0005″) to about 0.254 mm (0.010″). The thickness of the inner insulator 40 provides sufficient thermal conductivity allowing cooling to be conveyed to the outer conductor 50 and allow cooling of the outer conductor 50. This allows heat to be removed from the outer conductor 50. This may allow a larger lesion to be produced and minimizes charring of tissue. In one specific example, PET is used in insulators 40 and 60, each having a width of about 0.03175 mm (0.00125″).
In one embodiment of a method aspect of the present invention, the probe 100 is used to treat a region within a patient's body. In one embodiment, the region may comprise tissue with varying composition. In one such embodiment, the tissue may comprise any one of or a combination of vascular tissue, soft tissue, trabecular bone tissue, cortical bone tissue, fatty tissue, tumor or nervous tissue.
In one specific embodiment the probe 100 is placed within a vertebral body. For example, as shown in
Nerve stimulation can be used to position a probe. In bipolar nerve stimulation applications, the stimulation effects are not symmetric about each electrode. One electrode will have a larger stimulation capacity for a given biphasic wave. The electrode that is closest to a stimulated nerve can be identified by manipulating (reversing the polarity). Balanced stimulation of nerves can be achieved by alternating the polarity in an balanced manner. For example, 10 pulses could be delivered with a first electrode as the control electrode to more intensely stimulate the nerves nearest to it, and then 10 pulses could be delivered with a second electrode as the control electrode. An embodiment of a method using such a procedure to help position a probe includes the steps of: emitting a stimulation pulse comprising a continuous train of biphasic waves at a set frequency, navigating the active tip through tissue, and reversing the polarity of the two electrodes to identify which electrode a stimulated nerve is in closest to.
The probe 100 may improve heating capability in the vicinity of a non-conductive structure. The probe 100 provides energy in a bipolar manner and may be used in the vicinity of a cortical bone structure or other non-conductive structures to provide treatment to the non-conductive structure through indirect thermal conduction. Thus, probe 100 may be used to treat structures that are non-conductive in monopolar RF applications, where the energy transmission to a ground may be limited as the non-conductive structure is encountered in the energy pathway to the ground.
In another example, probe 100 may be used to target nerves at other locations within the vertebral body. In still another example, the probe 100 may be positioned substantially adjacent to or in the vicinity of any other bone tissue. In yet another example probe 100 may be used to treat a highly vascular tissue such as liver. In some embodiments, the probe 100 may be used to provide uniform or consistent lesions in the vicinity of bone or variable tissue. In other words, the probe 100 may be used to provide lesions that are substantially homogeneous.
In one particular embodiment an introducer needle assembly may be inserted and advanced to a target location within a patient's body. The introducer needle assembly may comprise a cannula with a stylet disposed therein. In one example, the target location is a vertebral body as shown in
Bipolar lesions of different geometry can be created by manipulating the duration and intensity energy delivered through each electrode as the control electrode. This is related to the higher tissue temperatures being found around the control electrode. Manipulating a bipolar probe can create lesions that are peanut, mushroom or symmetric ellipsoid shaped. Keeping each electrode active for 50 percent of the time can help in creating symmetrical or more symmetrical lesions.
In one example, RF energy is supplied by an RF generator in a bipolar manner to probe 100. The power output of the RF generator may be temperature controlled. In one embodiment, direct tissue temperature monitoring is used in conjunction with internal cooling when supplying RF power to form a lesion. The power output may be adjusted based on the measured temperature response of the tissue to RF heating under cooling. The temperature response of the target tissue may be monitored using the temperature sensor 80.
One embodiment is for a system in which the user puts the selected coolant temperature into the system from a range from just above 0 degrees C. up to about 30 degrees C. The cooling fluid is delivered by a pump unit, which is controlled by the same generator that delivers energy. The flow rate (and correspondingly the amount of cooling) can be adjusted based on tissue characteristics and the intended lesion geometry.
The RF energy is delivered in a bipolar manner between conductors 30 and 50 and allows a lesion 90 to be formed adjacent the active tip 70. Three factors in controlling lesion size and shape (lesion geometry) are temperature, time of procedure and active tip geometry which includes length of the active tip segments and ratios of the segments lengths. In one example the active tip 70 has a length of about 20 mm, and the distal electrode 32, the exposed inner insulator 40 and the proximal electrode 52, have a length ratio L1:L2:L3 of about 7:6:7. A ramp rate of about 10° C./min is used in order to reach a set temperature of about 65° C. to about 70° C. The power is supplied for about 15 minutes, resulting in a lesion having a size of about 30 mm×23 mm, with a lesion volume of about 8.3 cm3.
In another example an active tip 70 with a length of about 30 mm is used, and the distal electrode 32, the exposed insulator 40, and the proximal electrode 52 have a length ratio L1:L2:L3 of about 1:1:1. A ramp rate of about 20° C./min may be used. In one instance of this example, the ramp rate may be used to achieve a set temperature of about 100° C. The power is supplied for about 20 minutes, resulting in a lesion size of about 45 mm×35 mm, with a lesion volume of about 28.9 cm3.
In yet another example, a ramp rate of about 40° C./min is used to achieve a set temperature of about 90° C. Power is applied for about 5 minutes, resulting in a lesion size of about 15 mm×15 mm with a volume of about 1.8 cm3. In some embodiments, the tissue temperature may be maintained at between about 40 degrees and about 100 degrees.
In some cases, the predictability of lesioning is improved by the use of external monitoring electrodes. For example, placing a monitoring electrode at the periphery of a centrally-formed lesion can help a physician decide when to stop lesioning to ensure an adequate size or the monitoring electrode could be in communication with a generator with a control program that controls energy delivery. The output of a generator could be controlled by one or more monitoring electrode such as temperature monitoring electrodes. One example includes placing at least one external temperature sensor at the boundary of a desired lesion, monitoring the at least one external temperature sensor during energy delivery, and determining the lesion is complete when the external temperature reaches a predefined value.
In some embodiments, the power may be delivered at from about 1 Watt to about 100 Watts. In another example power may be delivered at from about 1 Watt to about 50 Watts. In other embodiments, greater than 100 Watts of power may be delivered by the RF energy delivery source. In still another embodiment, less than 1 Watt of power may be delivered. In some embodiments power may be delivered for a duration of between about 2 minutes to about 30 minutes. In other embodiments power may be applied for less than 2 minutes or greater than 30 minutes.
In some embodiments, the ramp rate may range from about 2° C./min to about 100° C./min. In one example, the ramp rate may be about 10° C./min. In another example, ramp rate may be about 20° C./min. In still another example, ramp rate may be about 40° C./min. In one embodiment the rap rate may be set to optimize the tissue response to achieve the set temperature. This may prevent charring, desiccation or vaporization of tissue. In some embodiments, the power supplied to the bipolar coaxial probe 100 may be less than power supplied to a monopolar probe to achieve as equivalent lesion.
Thus, as described hereinabove, an electrosurgical probe with internal cooling can be particularly useful, for example, in systems and methods for lesioning in bone and other tissue. In some embodiments, the probe is comprised of at least two electrically isolated electrical conductors which are operable to deliver energy in a bipolar manner. One embodiment of such a probe includes an inner conductor inside an outer conductor. The inner electrical conductor includes a lumen for the internal circulation of a cooling fluid. The probe also has an electrical insulator layer between the inner and outer electrical conductors for electrically isolating the electrical conductors. The electrical insulator has sufficient thermal conductivity to allow for cooling of the outside electrical conductor by cooling fluid circulating within the lumen of the inner electrical conductor. Thus, only one conductor is cooled directly, i.e. with contact of the cooling fluid, while the other conductor is indirectly cooled. When used in a system, the probe could enable temperature monitoring to provide data for controlling the delivery of energy through electrodes to tissue and for controlling the flow of cooling fluids to the electrodes.
The embodiments of the invention described above are intended to be exemplary only. The scope of the invention is therefore intended to be limited solely by the scope of the appended claims.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.
Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the broad scope of the appended claims. All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention.
The present application is a divisional application which claims the benefit of U.S. patent application Ser. No. 13/660,353, which is a continuation-in-part of international application PCT/CA2011/050203, filed Apr. 15, 2011, which claims the benefit of U.S. provisional patent application 61/328,118, filed on Apr. 26, 2010. All of the aforementioned applications are hereby incorporated by reference in their entirety.
|6129726||Edwards et al.||Oct 2000||A|
|6524308||Muller et al.||Feb 2003||B1|
|7216001||Hacker et al.||May 2007||B2|
|20030212394||Pearson et al.||Nov 2003||A1|
|20040167517||Desinger et al.||Aug 2004||A1|
|20050177209||Leung et al.||Aug 2005||A1|
|20060111706||Truckai et al.||May 2006||A1|
|20070016185||Tullis et al.||Jan 2007||A1|
|20070027449||Godara et al.||Feb 2007||A1|
|20080033418||Nields et al.||Feb 2008||A1|
|20090156981||Fay et al.||Jun 2009||A1|
|20100049190||Long et al.||Feb 2010||A1|
|20100152725||Pearson et al.||Jun 2010||A1|
|20130060244||Godara et al.||Mar 2013||A1|
|International Report on Patentability for Application: PCT/CA2011/050203 dated Oct. 30, 2012.|
|Restriction Requirement and Response for U.S. Appl. No. 13/660,353 received on Sep. 8, 2014.|
|Non-Final Office Action and Response for U.S. Appl. No. 13/660,353 received on Nov. 21, 2014.|
|Non-Final Office Action for U.S. Appl. No. 13/660,353 received on Apr. 6, 2015.|
|Restriction Requirement and Response for U.S. Appl. No. 13/643,310, mailed on Sep. 25, 2014.|
|Non-Final Office Action for U.S. Appl. No. 13/643,310, mailed on Dec. 15, 2014.|
|20160113704 A1||Apr 2016||US|